Cocoa and Chocolate their clinical benefits: Insights in study design

Duane Mellor; Ekavi Georgousopoulou; Nenad Naumovski

doi:10.1079/PAVSNNR201712018

Cocoa and Chocolate their clinical benefits: Insights in study design

Duane Mellor
, Ekavi Georgousopoulou
, Nenad Naumovski

Harokopio University
University of Canberra

Research output: Contribution to journal › Review article › peer-review

3 Citations (Scopus)

334 Downloads (Pure)

Abstract

Randomised controlled trials and meta-analyses have demonstrated the potential
protective effect of cocoa and chocolate consumption with respect to Cardiovascular Disease (CVD) risk markers. Findings from experimental studies are in concordance with observational data, which includes reduction in clinical disease (especially stroke) being associated with chocolate consumption. However, the effect size of any benefit, and the exact mechanism of action due to variability in reporting of dose and type potential bioactive compounds remains unclear. Thus, the present review aimed to analyse the published work where cocoa and chocolate has the been assessed for its potential to protect against CVD and highlight the role of study design and type of product used in the variances of outcomes and how that might be used in formulating health advice.

Publisher statement: This material has been published in CAB Reviews, Vol 12, Issue 018, 1-7, the only accredited archive of the content that has been certified and accepted after peer review. Copyright and all rights therein are retained by CABl. www.cabi.org/CABReviews

Original language	English
Pages (from-to)	1-7
Number of pages	7
Journal	CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources
Volume	12
Issue number	018
DOIs	https://doi.org/10.1079/PAVSNNR201712018
Publication status	Published - 3 Jul 2017

Bibliographical note

Accepted for publication in CAB Reviews as of 26th April 2017. After publication, authors may update this notice to read, This material has been published in CAB Reviews, 12 (18), July 2017 the only accredited archive of the content that has been certified and accepted after peer review. Copyright and all rights therein are retained by CABl - www.cabi.org/CABReviews.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1079/PAVSNNR201712018

Post-PrintAccepted author manuscript, 404 KB

Cite this

@article{02b775b06cc34849bd182408d069c655,

title = "Cocoa and Chocolate their clinical benefits: Insights in study design",

abstract = "Randomised controlled trials and meta-analyses have demonstrated the potential protective effect of cocoa and chocolate consumption with respect to Cardiovascular Disease (CVD) risk markers. Findings from experimental studies are in concordance with observational data, which includes reduction in clinical disease (especially stroke) being associated with chocolate consumption. However, the effect size of any benefit, and the exact mechanism of action due to variability in reporting of dose and type potential bioactive compounds remains unclear. Thus, the present review aimed to analyse the published work where cocoa and chocolate has the been assessed for its potential to protect against CVD and highlight the role of study design and type of product used in the variances of outcomes and how that might be used in formulating health advice. Publisher statement: This material has been published in CAB Reviews, Vol 12, Issue 018, 1-7, the only accredited archive of the content that has been certified and accepted after peer review. Copyright and all rights therein are retained by CABl. www.cabi.org/CABReviews ",

author = "Duane Mellor and Ekavi Georgousopoulou and Nenad Naumovski",

note = "Accepted for publication in CAB Reviews as of 26th April 2017. After publication, authors may update this notice to read, This material has been published in CAB Reviews, 12 (18), July 2017 the only accredited archive of the content that has been certified and accepted after peer review. Copyright and all rights therein are retained by CABl - www.cabi.org/CABReviews. ",

year = "2017",

month = jul,

day = "3",

doi = "10.1079/PAVSNNR201712018",

language = "English",

volume = "12",

pages = "1--7",

journal = "CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources",

issn = "1749-8848",

publisher = "CABI International",

number = "018",

}

TY - JOUR

T1 - Cocoa and Chocolate their clinical benefits

T2 - Insights in study design

AU - Mellor, Duane

AU - Georgousopoulou, Ekavi

AU - Naumovski, Nenad

N1 - Accepted for publication in CAB Reviews as of 26th April 2017. After publication, authors may update this notice to read, This material has been published in CAB Reviews, 12 (18), July 2017 the only accredited archive of the content that has been certified and accepted after peer review. Copyright and all rights therein are retained by CABl - www.cabi.org/CABReviews.

PY - 2017/7/3

Y1 - 2017/7/3

N2 - Randomised controlled trials and meta-analyses have demonstrated the potential protective effect of cocoa and chocolate consumption with respect to Cardiovascular Disease (CVD) risk markers. Findings from experimental studies are in concordance with observational data, which includes reduction in clinical disease (especially stroke) being associated with chocolate consumption. However, the effect size of any benefit, and the exact mechanism of action due to variability in reporting of dose and type potential bioactive compounds remains unclear. Thus, the present review aimed to analyse the published work where cocoa and chocolate has the been assessed for its potential to protect against CVD and highlight the role of study design and type of product used in the variances of outcomes and how that might be used in formulating health advice. Publisher statement: This material has been published in CAB Reviews, Vol 12, Issue 018, 1-7, the only accredited archive of the content that has been certified and accepted after peer review. Copyright and all rights therein are retained by CABl. www.cabi.org/CABReviews

AB - Randomised controlled trials and meta-analyses have demonstrated the potential protective effect of cocoa and chocolate consumption with respect to Cardiovascular Disease (CVD) risk markers. Findings from experimental studies are in concordance with observational data, which includes reduction in clinical disease (especially stroke) being associated with chocolate consumption. However, the effect size of any benefit, and the exact mechanism of action due to variability in reporting of dose and type potential bioactive compounds remains unclear. Thus, the present review aimed to analyse the published work where cocoa and chocolate has the been assessed for its potential to protect against CVD and highlight the role of study design and type of product used in the variances of outcomes and how that might be used in formulating health advice. Publisher statement: This material has been published in CAB Reviews, Vol 12, Issue 018, 1-7, the only accredited archive of the content that has been certified and accepted after peer review. Copyright and all rights therein are retained by CABl. www.cabi.org/CABReviews

UR - https://www.scopus.com/pages/publications/85023632940

U2 - 10.1079/PAVSNNR201712018

DO - 10.1079/PAVSNNR201712018

M3 - Review article

SN - 1749-8848

VL - 12

SP - 1

EP - 7

JO - CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources

JF - CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources

IS - 018

ER -

Cocoa and Chocolate their clinical benefits: Insights in study design

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this